Oxylanthanum Carbonate

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Chronic Kidney Disease Requiring Chronic Dialysis

Drug Information

Target Indication

Chronic Kidney Disease Requiring Chronic Dialysis

Clinical Trial

Last updated: 12/4/2025

Patent & Exclusivity

ActiveRLD

Latest Patent Expiry

Dec 1, 2030(4y 8m)

Patents Listed

Application

Drug Science

Mechanism of action & safety profile

Developer

UNCY

Unicycive Therapeutics, Inc.